WallStSmart
TOI

Oncology Institute Inc

NASDAQ: TOI · HEALTHCARE · MEDICAL CARE FACILITIES

$4.05
+4.92% today

Updated 2026-05-01

Market cap
$366.69M
P/E ratio
P/S ratio
0.73x
EPS (TTM)
$-0.54
Dividend yield
52W range
$2 – $5
Volume
1.8M

Oncology Institute Inc (TOI) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-7.5%
Last 4 quarters
Revenue YoY growth
+41.6%
Most recent quarter
EPS YoY growth
+55.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-5.4%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-8.3%
2025-11-12
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-05$-0.06+29.7%$2.85$2.78-2.5%
2025-11-12$-0.14-27.3%$3.36$3.08-8.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.09$-0.06+29.7%$141.96M+41.6%
2025-09-30$-0.11$-0.14-27.3%$136.56M+36.7%
2025-06-30$-0.12$-0.15-25.0%$119.80M+21.5%
2025-03-31$-0.21$104.41M+10.3%
2024-12-31$-0.08$-0.14-78.7%$100.27M+16.9%
2024-09-30$-0.06$-0.18-191.8%$99.90M+21.8%
2024-06-30$-0.10$-0.17-70.0%$98.58M+22.9%
2024-03-31$-0.12$-0.22-83.3%$94.67M+24.2%
2023-12-31$-0.11$-0.21-90.9%$85.79M
2023-09-30$-0.13$-0.19-46.2%$82.03M
2023-06-30$-0.17$-0.19-11.8%$80.22M
2023-03-31$-0.17$-0.33-94.1%$76.19M

Frequently asked questions

Has Oncology Institute Inc beaten earnings estimates?
Oncology Institute Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -7.5% over the last 3 quarters.
How does TOI stock react to earnings?
TOI stock has moved an average of -5.4% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Oncology Institute Inc's revenue growth rate?
Oncology Institute Inc reported year-over-year revenue growth of +41.6% in its most recent quarter, with EPS growing +55.7% year-over-year.